Figure 1
From: Medical examination powers miR-194-5p as a biomarker for postmenopausal osteoporosis
Literature-reported miRNA biomarkers for human diseases. Comparison of the recognition effects for high-risk subjects using single miRNA biomarkers and panel miRNA biomarkers (A) or from the aspect of disease category (B). A scatter plot was used and the data expressed as mean ± SD. Percentage distribution of studies (C) and coefficient of variation of AUCs (D) as the number of subjects was concerned. (E) Illustration of all the miRNA-disease associations in a network. The black solid-line and black dot-line indicate that a miRNA is used as a single biomarker or as an element for a panel biomarker with other miRNAs or non-miRNA markers, respectively; blue solid-line represents that a miRNA can be applied as a single biomarker and also used as a biomarker panel element. Only disease abbreviations are shown in green nodes for human diseases.
